In this episode Beats Roundtable, Wall Street Beats pros David Maris, Robert Marcin, and Charlie Peabody dive into key market trends, covering the latest developments in banking, biotech, and retail. They discuss sluggish bank fundamentals, Wells Fargo’s growth strategy, Citi’s valuation boost, and Goldman Sachs’ risk exposure. Plus, insights on biotech movers like Ultragenyx and Teva, along with a deep dive into American Eagle’s stock potential.